Cargando…
Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
Anti-IgLON5 disease is a relatively new neurological entity with the first cases reported in 2014. So far, less than 70 articles on this topic have been published. Due to its unspecific symptomatology, diverse progression, novelty and ambiguous character, it remains a difficulty for both clinical pr...
Autores principales: | Madetko, Natalia, Marzec, Weronika, Kowalska, Agata, Przewodowska, Dominika, Alster, Piotr, Koziorowski, Dariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921982/ https://www.ncbi.nlm.nih.gov/pubmed/35300333 http://dx.doi.org/10.3389/fimmu.2022.852215 |
Ejemplares similares
-
Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
por: Landa, Jon, et al.
Publicado: (2023) -
Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
por: Landa, Jon, et al.
Publicado: (2023) -
Ocular Motor Abnormalities in Anti-IgLON5 Disease
por: Macher, Stefan, et al.
Publicado: (2021) -
IgLON5 disease responsive to immunotherapy
por: Bonello, Michael, et al.
Publicado: (2017) -
Understanding anti-IgLON5 disease
por: Graus, Francesc, et al.
Publicado: (2017)